| Number of patients, male | 11 |
| Number of patients, female | 13 |
| Stage | IV |
| Age: median (range) | 57 (22.3-69.8) years |
| Number of prior systemic therapies: median (range) | 2 (1-6) |
| Performance status: ECOG | 0-7 |
| 1-17 | |
| 2-0 | |
| 3-0 | |
| 4-0 | |
| Cancer types or histologic subtypes | Neuroendocrine carcinoma, 18; Neuroendocrine tumor , 16 |
| Note | The primary tumor site of 10 patients was gastrointestinal and that of 7 was pancreatic. The other primary sites included liver (n = 2), lung (n=1), adrenal gland (n = 1), cervix (n = 1), and sacroiliac (n = 1). The median Ki-67 was 60%. |